Update on Diffuse Lung Disease in Children

Hime, 2015, Childhood interstitial lung disease: a systematic review, Pediatr Pulmonol, 50, 1383, 10.1002/ppul.23183 Grosse, 2004, Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs, MMWR Recomm Rep, 53, 1 Akimoto, 2014, Hereditary interstitial lung diseases manifesting in early childhood in Japan, Pediatr Res, 76, 453, 10.1038/pr.2014.114 Soares, 2013, Childhood interstitial lung diseases: an 18-year retrospective analysis, Pediatrics, 132, 684, 10.1542/peds.2013-1780 Deutsch, 2007, Diffuse lung disease in young children: application of a novel classification scheme, Am J Respir Crit Care Med, 176, 1120, 10.1164/rccm.200703-393OC Kurland, 2013, An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy, Am J Respir Crit Care Med, 188, 376, 10.1164/rccm.201305-0923ST Bush, 2015, European protocols for the diagnosis and initial treatment of interstitial lung disease in children, Thorax, 70, 1078, 10.1136/thoraxjnl-2015-207349 Vece, 2011, Diagnosis and management of diffuse lung disease in children, Paediatr Respir Rev, 12, 238, 10.1016/j.prrv.2011.04.001 Brody, 2010, Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT, AJR Am J Roentgenol, 194, 238, 10.2214/AJR.09.2743 Chang, 1998, Post-infectious bronchiolitis obliterans: clinical, radiological and pulmonary function sequelae, Pediatr Radiol, 28, 23, 10.1007/s002470050286 Guillerman, 2010, Imaging of childhood interstitial lung disease, Pediatr Allergy Immunol Pulmonol, 23, 43, 10.1089/ped.2010.0010 Nogee, 2010, Genetic basis of children's interstitial lung disease, Pediatr Allergy Immunol Pulmonol, 23, 15, 10.1089/ped.2009.0024 Kim, 2014, Humidifier disinfectant-associated children's interstitial lung disease, Am J Respir Crit Care Med, 189, 48, 10.1164/rccm.201306-1088OC Buchvald, 2011, Frequency, treatment, and functional outcome in children with hypersensitivity pneumonitis, Pediatr Pulmonol, 46, 1098, 10.1002/ppul.21479 Griese, 2013, Hypersensitivity pneumonitis: lessons for diagnosis and treatment of a rare entity in children, Orphanet J Rare Dis, 8, 121, 10.1186/1750-1172-8-121 Langston, 2006, A protocol for the handling of tissue obtained by operative lung biopsy: recommendations of the chILD pathology co-operative group, Pediatr Dev Pathol, 9, 173, 10.2350/06-03-0065.1 Rice, 2013, Diffuse lung disease in infancy and childhood: expanding the chILD classification, Histopathology, 63, 743, 10.1111/his.12185 Fan, 2015, Diffuse lung disease in biopsied children 2-18 years of age: application of the chILD classification scheme, Ann Am Thorac Soc, 12, 1498, 10.1513/AnnalsATS.201501-064OC Deterding, 2005, Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia, Pediatr Pulmonol, 40, 157, 10.1002/ppul.20243 Vece, 2012, Diffuse alveolar hemorrhage in children, 848 Fauci, 1983, Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years, Ann Intern Med, 98, 76, 10.7326/0003-4819-98-1-76 de Groot, 1996, Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole, Arthritis Rheum, 39, 2052, 10.1002/art.1780391215 Jayne, 2003, A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies, N Engl J Med, 349, 36, 10.1056/NEJMoa020286 Stone, 2010, Rituximab versus cyclophosphamide for ANCA-associated vasculitis, N Engl J Med, 363, 221, 10.1056/NEJMoa0909905 Vij, 2013, Diagnosis and treatment of connective tissue disease-associated interstitial lung disease, Chest, 143, 814, 10.1378/chest.12-0741 Yancheva, 2015, Bombesin staining in neuroendocrine cell hyperplasia of infancy (NEHI) and other childhood interstitial lung diseases (chILD), Histopathology, 67, 501, 10.1111/his.12672 Lyu, 2014, A case of neuroendocrine cell hyperplasia of infancy (NEHI), Zhonghua Er Ke Za Zhi, 52, 317 Lange, 2014, Neuroendocrine cell hyperplasia of infancy—case study, Pneumonol Alergol Pol, 82, 358, 10.5603/PiAP.2014.0045 Young, 2013, A mutation in TTF1/NKX2.1 is associated with familial neuroendocrine cell hyperplasia of infancy, Chest, 144, 1199, 10.1378/chest.13-0811 Popler, 2013, Bronchoalveolar lavage fluid cytokine profiles in neuroendocrine cell hyperplasia of infancy and follicular bronchiolitis, Orphanet J Rare Dis, 8, 175, 10.1186/1750-1172-8-175 Lukkarinen, 2013, Neuroendocrine cell hyperplasia of infancy: a prospective follow-up of nine children, Arch Dis Child, 98, 141, 10.1136/archdischild-2012-302115 Kerby, 2013, Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy, Pediatr Pulmonol, 48, 1008, 10.1002/ppul.22718 Gomes, 2013, Diagnostic criteria and follow-up in neuroendocrine cell hyperplasia of infancy: a case series, J Bras Pneumol, 39, 569 Young, 2011, Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders, Chest, 139, 1060, 10.1378/chest.10-1304 Popler, 2010, Familial neuroendocrine cell hyperplasia of infancy, Pediatr Pulmonol, 45, 749, 10.1002/ppul.21219 Doan, 2009, Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism, Thorax, 64, 677, 10.1136/thx.2008.107979 Brody, 2006, Neuroendocrine cell hyperplasia of infancy (NEHI), Pediatr Radiol, 36, 1328, 10.1007/s00247-006-0302-3 Hamvas, 2013, Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1, Chest, 144, 794, 10.1378/chest.12-2502 Ansari, 2012, Secondary pulmonary alveolar proteinosis after unrelated cord blood hematopoietic cell transplantation, Pediatr Transplant, 16, E146, 10.1111/j.1399-3046.2011.01487.x Chaulagain, 2014, Secondary pulmonary alveolar proteinosis in hematologic malignancies, Hematol Oncol Stem Cell Ther, 7, 127, 10.1016/j.hemonc.2014.09.003 Ishii, 2014, Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan, BMC Pulm Med, 14, 37, 10.1186/1471-2466-14-37 Raj, 2014, Pulmonary alveolar proteinosis secondary to Pneumocystis jiroveci infection in an infant with common variable immunodeficiency, Indian J Pediatr, 81, 929, 10.1007/s12098-013-1027-6 Tran Van Nhieu, 1990, Pulmonary alveolar proteinosis associated with Pneumocystis carinii. Ultrastructural identification in bronchoalveolar lavage in AIDS and immunocompromised non-AIDS patients, Chest, 98, 801, 10.1378/chest.98.4.801 Griese, 2015, Surfactant lipidomics in healthy children and childhood interstitial lung disease, PLoS One, 10, e0117985, 10.1371/journal.pone.0117985 Rosen, 2005, Hydroxychloroquine and surfactant protein C deficiency, N Engl J Med, 352, 207, 10.1056/NEJM200501133520223 Abou Taam, 2009, Familial interstitial disease with I73T mutation: a mid- and long-term study, Pediatr Pulmonol, 44, 167, 10.1002/ppul.20970 Hepping, 2013, Successful treatment of neonatal respiratory failure caused by a novel surfactant protein C p.Cys121Gly mutation with hydroxychloroquine, J Perinatol, 33, 492, 10.1038/jp.2012.131 Kitazawa, 2013, Interstitial lung disease in two brothers with novel compound heterozygous ABCA3 mutations, Eur J Pediatr, 172, 953, 10.1007/s00431-013-1977-8 Avital, 2014, Natural history of five children with surfactant protein C mutations and interstitial lung disease, Pediatr Pulmonol, 49, 1097, 10.1002/ppul.22971 Williamson, 2014, Ten-year follow up of hydroxychloroquine treatment for ABCA3 deficiency, Pediatr Pulmonol, 49, 299, 10.1002/ppul.22811 Winter, 2014, Neonatal respiratory insufficiency caused by an (homozygous) ABCA3-stop mutation: a systematic evaluation of therapeutic options, Klin Padiatr, 226, 53, 10.1055/s-0033-1363687 Rama, 2013, Lung transplantation for childhood diffuse lung disease, Pediatr Pulmonol, 48, 490, 10.1002/ppul.22634 Liptzin, 2015, Chronic ventilation in infants with surfactant protein C mutations: an alternative to lung transplantation, Am J Respir Crit Care Med, 191, 1338, 10.1164/rccm.201411-1955LE Wambach, 2014, Genotype-phenotype correlations for infants and children with ABCA3 deficiency, Am J Respir Crit Care Med, 189, 1538, 10.1164/rccm.201402-0342OC Cameron, 2005, A common mutation in the surfactant protein C gene associated with lung disease, J Pediatr, 146, 370, 10.1016/j.jpeds.2004.10.028 Kroner, 2015, Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients, Eur Respir J, 46, 197, 10.1183/09031936.00129414 Peca, 2015, Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations, Eur J Hum Genet, 23, 1033, 10.1038/ejhg.2015.45 deMello, 1994, Ultrastructure of lung in surfactant protein B deficiency, Am J Respir Cell Mol Biol, 11, 230, 10.1165/ajrcmb.11.2.8049084 Shulenin, 2004, ABCA3 gene mutations in newborns with fatal surfactant deficiency, N Engl J Med, 350, 1296, 10.1056/NEJMoa032178 Whitsett, 2015, Diseases of pulmonary surfactant homeostasis, Annu Rev Pathol, 10, 371, 10.1146/annurev-pathol-012513-104644 Martinez-Moczygemba, 2008, Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1, J Exp Med, 205, 2711, 10.1084/jem.20080759 Suzuki, 2008, Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA, J Exp Med, 205, 2703, 10.1084/jem.20080990 Tanaka, 2011, Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB, J Med Genet, 48, 205, 10.1136/jmg.2010.082586 Suzuki, 2010, Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy, Am J Respir Crit Care Med, 182, 1292, 10.1164/rccm.201002-0271OC Happle, 2014, Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis, Sci Transl Med, 6, 250ra113, 10.1126/scitranslmed.3009750 Lachmann, 2014, Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis, Am J Respir Crit Care Med, 189, 167, 10.1164/rccm.201306-1012OC Suzuki, 2014, Pulmonary macrophage transplantation therapy, Nature, 514, 450, 10.1038/nature13807 Fullmer, 2005, Pulmonary capillaritis in children: a review of eight cases with comparison to other alveolar hemorrhage syndromes, J Pediatr, 146, 376, 10.1016/j.jpeds.2004.10.025 Sacri, 2015, Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study, Nephrol Dial Transplant, 30, i104 Guillevin, 2014, Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis, N Engl J Med, 371, 1771, 10.1056/NEJMoa1404231 Calich, 2014, Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients, J Autoimmun, 50, 135, 10.1016/j.jaut.2014.03.002 Watkin, 2015, COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis, Nat Genet, 47, 654, 10.1038/ng.3279 Lo, 2015, AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy, Science, 349, 436, 10.1126/science.aaa1663 Milner, 2015, Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations, Blood, 125, 591, 10.1182/blood-2014-09-602763